Bioanalytical Systems (BASI) Short Interest Ratio & Short Volume

Short interest is the volume of Bioanalytical Systems shares that have been sold short but have not yet been closed out or covered. As of February 26th, traders have sold 57,500 shares of BASI short. 0.79% of Bioanalytical Systems' shares are currently sold short. Learn More on Bioanalytical Systems' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.79% of Bioanalytical Systems' floating shares are currently sold short.

Bioanalytical Systems saw a increase in short interest in February. As of February 26th, there was short interest totaling 57,500 shares, an increase of 7.5% from the previous total of 53,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Bioanalytical Systems currently has issued a total of 11,131,000 shares. Some of Bioanalytical Systems' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bioanalytical Systems currently has a public float of 7,260,000 shares.

0.79% of Bioanalytical Systems' shares are currently sold short. Here is how the short interest of companies compare to Bioanalytical Systems: Luna Innovations Incorporated (6.66%), bioAffinity Technologies, Inc. (1.28%), Inotiv, Inc. (4.07%), AVROBIO, Inc. (0.37%), Homology Medicines, Inc. (0.81%), Eledon Pharmaceuticals, Inc. (0.43%), Gain Therapeutics, Inc. (1.02%), ARCA biopharma, Inc. (1.37%), IceCure Medical Ltd (1.76%), Sensus Healthcare, Inc. (0.26%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($5.72 billion), Analog Devices, Inc. ($5.42 billion), Charter Communications, Inc. ($4.94 billion), Snap Inc. ($3.85 billion), Airbnb, Inc. ($2.46 billion), Warner Bros. Discovery, Inc. ($2.34 billion), Futu Holdings Limited ($2.31 billion), The Kroger Co. ($2.05 billion), Palo Alto Networks, Inc. ($1.89 billion), and Marathon Petroleum Co. ($1.87 billion). View all of the most shorted stocks.

Short selling BASI is an investing strategy that aims to generate trading profit from Bioanalytical Systems as its price is falling. BASI shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bioanalytical Systems occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BASI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BASI, twice per month. The most recent reporting period available is February, 26 2021.